FDA pulls high-dose Zofran The anti-nausea drug ondansetron has been pulled from the market due to potential for serious cardiac risks. The 32 mg, single intravenous (IV) dose of the anti-nausea drug ...
Ondansetron (as base) 4mg, 8mg; strawberry flavor; contains phenylalanine. See full labeling. Highly emetogenic chemotherapy: 24mg once 30 mins before start of single-day chemotherapy (multi-day, ...
Screening for cancer-related fatigue (CRF) in a thoracic oncology clinic is feasible No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2005 ASCO Annual ...
Drug discontinued-text The Food and Drug Administration (FDA) has posted a discontinuation notice for Zofran Oral Solution (ondansetron; Novartis). The Food and Drug Administration (FDA) has posted a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback